Expert Interview
A Third Perspective: Discussing the NASH landscape in the aftermath of the Akero's efruxifermin results
Ticker(s): AKRO, ENTB, MDGL, LLY, NVOInstitution: Wake Forest University School of Medicine
- Professor of Medicine and Molecular Med and Translational Sciences, Director of the Laboratory for Liver & Metabolic Disorders at Wake Forest University School of Medicine/NC Baptist Hospital.
- Manages several hundred patients with NASH.
- Research focuses on porphyrin and heme metabolism, effects of heme and iron on gene expression and intermediary metabolism, and drug- and herbal supplement-induced liver injury.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
